The Application dimension of Ultrasound Coaxial Cable segmentation delineates three principal end‑use clusters: Diagnostic Imaging, Therapeutic Procedures, and R&D & Prototyping. Diagnostic Imaging—encompassing obstetric, cardiology, and musculoskeletal scanners—commands the largest share, driven by high‑volume hospital deployments and continuous upgrades to higher‑frequency transducers. Therapeutic Procedures, such as focused‑ultrasound ablation and physiotherapy devices, represent a growing niche, reflecting expanding clinical adoption of minimally invasive treatments. R&D & Prototyping, while smaller, fuels innovation pipelines and early‑stage product validation, influencing cable specification trends like low‑loss and high‑temperature tolerance. Each sub‑segment contributes proportionally to the overall market size, with demand intensity shaped by procedure frequency, equipment lifecycle, and regulatory pathways. Accurate attribution of revenue to these application buckets is essential for forecasting, as shifts in clinical practice or research funding directly reshape the Ultrasound Coaxial Cable market landscape.